PubMed · 16584868
Alveolar cleft osteoplasty using tissue-engineered osteogenic material.
Abstract
The use of tissue-engineered osteogenic material comprising platelet-rich plasma and autologous mesenchymal stem cells isolated, expanded and induced to osteogenic potential in bone augmentation procedures as a replacement for autologous bone grafts, offers predictable results with minimal donor-site morbidity. This material was applied for an alveolar cleft osteoplasty of a 9-year-old female patient. Serial computed tomograms showed the regenerated bone extending from the cleft walls after 3 months and bridging the cleft after 6 months, with 79.1% of the grafted region after 9 months at the time when the canine and lateral incisor in the affected side erupted in the reconstructed alveolar ridge.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
H Hibi, Y Yamada, M Ueda, Y Endo. 2006-04-11. Alveolar cleft osteoplasty using tissue-engineered osteogenic material.. https://doi.org/10.1016/j.ijom.2005.12.007
Cite the original work for its findings. Save a collection to share your selection of sources.